ResearchMoz

Global and China Automotive Industrial Robotics Industry Report,2013 - 2014

Research In China
Published Date » 2014-01-21
No. Of Pages » 90
 The global industrial robotics market valued around USD11.156 billion in 2012, but the value slumped by 17% to USD9.249 billion in 2013 because of the yen depreciation and a significant decline in the average price of industrial robotics. 
   
 In 2013, the global shipment of industrial robotics slightly rose by 2%. Japan’s industrial robotics shipment fell by 7.3% to 106,225 sets, and the average selling price dropped from JPY4.72 million in 2012 to JPY4.52 million in 2013. Thanks to the strong recovery in Europe, the U.S. and Japan, their demand for industrial robotics will not be less than China in 2014. The global market value is expected to increase by 3.5% to USD9.569 billion in the same year. 
   
 Although Japan’s industrial robotics shipment declines, Japanese...
Table of Content

1 Introduction to Industrial Robotics
1.1 History
1.2 Cost Structure

2 Global Industrial Robotics Market
2.1 Scale
2.2 Regional Analysis
2.3 Downstream
2.4 Service Robotics
2.5 Industrial Distribution in China
2.6 China’s Import and Export
2.7 Market Share of Major Enterprises in China
2.8 USA Market

3 Industrial Robotics Industry
3.1 Supply Chain 
3.2 Global Industrial Ranking 
3.3 Japan's Industrial Research 
3.4 Japan's Industrial Structure 
3.5 Automotive Industrial Robotics Industry 
3.6 Overview of Chinese Automobile Market 
3.7 Status Quo of Chinese Automobile Market
3.7.1 Status Quo of Passenger Car Market 
3.7.2 Commercial Vehicle Market 
3.8 China Automobile Industry

4 Major Industrial Robotics Enterprises
4.1 ABB
4.2 FANUC
4.3 Kawasaki Heavy Industries
4.4 COMAU
4.5 Yaskawa Electric 
4.6 KUKA
4.6.1 REIS
4.7 OTC (DAIHEN)
4.8 IGM
4.9 NACHI
4.10 ADEPT
4.11 NABTESCO
4.12 HARMONIC DRIVE SYSTEM
4.13 Shenyang SIASUN
4.14 DURR

List of Tables


List of Figures

Upcoming Reports:

Email Marketing Industry - Global Market Size, Market Share, Trends, Analysis And Forecasts, 2012 - 2018
By - Transparency Market Research
Email marketing, a trend in its naïve stage and soon catching up, is driven by rising popularity of social media marketing and global internet reach and penetration. Businesses of all types, irrespective of their size and area of operations, are increasingly adopting to email marketing for the conceived benefits it provides.  Email marketing market size which was at USD 1.5 billion in the year 2010, is growing at a healthy CAGR of 20%, and is expected to reach market size of USD 6.5 billion by year 2018. The growth in the email marketing market is attributed...
Cloud Security Market- Global Forecast, Market Share, Size, Growth And Industry Analysis (2010-2017)
By - Transparency Market Research
Over the last few years, enterprise adoption of cloud computing has grown incrementally. However, security remains the most renowned issue with the adoption of cloud computing for companies. As enterprises are increasingly investing into clout infrastructure, technology vendors are finding new market opportunity of “cloud security” within the cloud computing market. Though the market is currently small, it is expected to grow exponentially over the next five years. The global cloud security market is estimated to be in excess of USD 6 billion by 2016. Among all the...
Pulmonary Arterial Hypertension (PAH) Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, And Forecast, 2012 - 2018
By - Transparency Market Research
Pulmonary arterial hypertension (PAH), a type of pulmonary hypertension results from high blood pressure associated with arteries of the lungs. In PAH, the arteries of the lungs (pulmonary arteries) become narrower than their actual size, giving rise to high blood pressure in the arteries of the lungs thus putting pressure on the right ventricle of the heart. Some of the main causes of occurrences of this disease are bad habits such as stressful lifestyle, intake of certain medicines etc. There is no exact treatment available for PAH but existing medication may help treat the symptoms....

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Nuclear Development Plans in China Gets Fresh Impetus
Mar 5, 2015  
The nuclear development plans of China got a renewed momentum on Wednesday as State Council gave a nod to build new reactors at the nuclear power plant located near Hongyan River. The unit 5 and 6 of the nuclear plant near Hongyan River, located in the northeastern province of Liaoning got approval for construction from the State Council. The council also mentioned that the construction should...
Indian Telecoms Bid at Spectrum War
Mar 5, 2015  
The Indian government on Wednesday managed to mop up nearly INR 60,000 crore with the spectrum auctions off to a wonderful start. Top bidders included Idea Cellular, Bharti Airtel, and Vodafone India who fought tooth and nail to gain secure airwaves in those areas where their licenses were nearing expiration. Reliance Jio Infocomm made a strenuous attempt to acquire as many data airwaves as...
South Korean Pharmaceutical Companies Extend Business with Saudi Arabia
Mar 5, 2015  
Four South Korean pharmaceutical companies will export their products to Saudi Arabia, including anticancer drugs and antibiotics, for the coming five years, South Korea’s Health Ministry informed this Wednesday, as a result of South Korean President Park Geun-hye's business trip to the Saudi Arabia this week. Ascertaining to the export agreement, representatives of these four Korean...
U.K. Government Slow to Stop Pharma R&D Slump
Mar 4, 2015  
When it comes to turnaround strategies, the focal point of the U.K. government is currently the life sciences industry. Recent data however shows that healthcare companies are spending less and less on research and development processes on drugs in the country. The Office of National Statistics released the data earlier this week. It shows the United Kingdom’s drug production...
Sun Pharma Buys Out GSK Australian Opiates Business
Mar 4, 2015  
Global pharmaceutical giant GSK announced on Tuesday that they had come to an agreement with Sun Pharmaceuticals Industries for the latter to buy out the opiates business in Australia owned by GSK. A joint statement was made by the two pharma top companies. The statement said that the companies’ respective wholly owned subsidiaries had already come to an agreement that was...